Literature DB >> 130180

Depression in patients with Parkinsonism.

A H Robins.   

Abstract

Forty-five patients with parkinsonism were carefully matched for age and sex with 45 chronically disabled control patients with a significantly more severe grade of physical handicap. Depression was measured by the Hamilton Rating Scale, and it was found that the parkinsonian group was very significantly more depressed than the control group (p less than 0-0001). Depression scores in both groups were unaffected by the patients's sex or by the severity of the disability. Analysis of the individual ratings of the Hamilton Scale showed that parkinsonian patients had significantly higher scores on items relating to suicide, work and interests, retardation, psychic anxiety, general somatic symptoms, and loss of insight. It was concluded that patients with parkinsonism suffer a degree of depression which cannot be solely a reaction to the stress of physical disability. This finding is discussed with reference to the monoamine hypothesis of depressive illness.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 130180     DOI: 10.1192/bjp.128.2.141

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  22 in total

1.  Specificity of affective and autonomic symptoms of depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; A W Forrester; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

Review 2.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

Review 3.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 4.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

5.  Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study.

Authors:  R Cantello; M Gilli; A Riccio; B Bergamasco
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

6.  Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse.

Authors:  R Cantello; M Aguggia; M Gilli; M Delsedime; I Chiardò Cutin; A Riccio; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

7.  Idiopathic Parkinson's disease and depression: a psychosomatic view.

Authors:  C J Todes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

8.  The pattern of depressive symptoms varies with progression of Parkinson's disease.

Authors:  S J Huber; D L Freidenberg; G W Paulson; E C Shuttleworth; J A Christy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

9.  Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.

Authors:  J Ulrichsen; J S Partilla; E M Dax
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 10.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.